Contribution: Industrial Research Assistance Program – Contributions to Firms
BioVectra Inc.
$1,874,945.00
COVID 19 - Feasibility Study to Manufacture a Vaccine
EF 2020-21 · 2020-09-21
Résumé
Enhanced conceptual engineering design for the installation of vaccine manufacturing capacity at BioVectra's current sites.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Charlottetown|Charlottetown, Prince Edward Island, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
101379949
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2020-09-21 | 2020-21 | $1,874,945.00 |
| 1 | 2020-09-21 | 2020-21 | $1,874,945.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 110 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 110 jours.
Agreement End Date
2021-06-30
Agreement Number
956502
Agreement Start Date
2020-09-21
Agreement Title
COVID 19 - Feasibility Study to Manufacture a Vaccine
Agreement Title (French)
COVID-19 - Étude de faisabilité pour la fabrication d'un vaccin
Agreement Type
Contribution
Agreement Value
$1,874,945.00
Amendment Date
2021-03-23
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Enhanced conceptual engineering design for the installation of vaccine manufacturing capacity at BioVectra's current sites.
Description (French)
Amélioration de la conception technique pour l'installation d'une capacité de fabrication de vaccins sur les sites actuels de BioVectra.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
101379949
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
BioVectra Inc.
Recipient Postal Code
C1E 2E6
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2020-2021-Q3-956502
